Researcher
Sigrid Stroobants
- Keywords:Medicine
- Disciplines:Cancer diagnosis, Biomarker evaluation, Nuclear imaging, Neurosciences not elsewhere classified
Affiliations
- Molecular Imaging and Radiology (MIRA) (Research group)
Responsible
From1 Jan 2019 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Member
From1 Sep 2008 → 31 Dec 2018
Infrastructure
1 - 1 of 1
- Flanders BioImaging (FBI/EBI) (Consortium partner)
Projects
21 - 29 of 29
- Biomarker based adaptive development in Alzheimer (BioAdaptAD).From1 Jan 2013 → 31 Dec 2016Funding: IWT / VLAIO - excluding impulse programmes, Industrial enterprises
- Activity-based probes for PET imaging of protease activity.From1 Jan 2013 → 31 Dec 2016Funding: BOF - Concerted Research Project from 1994
- Molecular imaging for early response assessment of drugs targeting the PI3K/mTOR pathway in an HER-2 amplified breast cancer model.From1 Oct 2012 → 30 Sep 2016Funding: BOF - Doctoral projects
- Design, synthesis and evaluation of new potent radioligands for PDE7 imaging and implication of PDE7 in neurological disorders.From1 Oct 2012 → 30 Sep 2015Funding: FWO Pegasus Marie Curie Fellowships
- VECTor/CT: simultaneous PET/SPECT/CT scanner for small animals.From28 Jun 2012 → 31 Dec 2017Funding: Own budget, for example: patrimony, inscription fees, gifts, Hercules - Small and Medium size research infrastructure, FWO Medium Size Research Infrastructure
- Transcranial magnetic stimulation for small animals: methods and device.From1 Jun 2012 → 31 May 2013Funding: IOF - Industrial Research Fund
- Immuno-positron emission tomography as a potential biomarker for diagnosis and treatment in Alzheimer disease.From1 Apr 2012 → 31 Mar 2014Funding: IWT / VLAIO - indirect funding by business world
- Development of uPA probes as tools for imaging and diagnostic applications.From1 May 2011 → 30 Apr 2013Funding: IOF - Industrial Research Fund
- Validation of Urokinase plasminogen activator (uPA) as a therapeutic target and biomarker.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 155
- Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)(2024)
Authors: Magdalena Mileva, Elisabeth G.E. de Vries, Thomas Guiot, Zena Wimana, Anne-Leen Deleu, Carolien P. Schroder, Yolene Lefebvre, Marianne Paesmans, Sigrid Stroobants, Manon Huizing, et al.
Pages: 1 - 10 - Design, synthesis, and evaluation of Trans-cyclooctene (TCO) and cis-dioxolane fused TCO (d-TCO) probes for bioorthogonal pretargeted PET imaging(2024)
Authors: Karuna Adhikari, Koen Augustyns, Filipe Elvas, Sigrid Stroobants
Number of pages: 244 - Prospective comparison of [¹⁸F]AlF-NOTA-octreotide PET/MRI to [⁶⁸Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients(2023)
Authors: Lennert Boeckxstaens, Elin Pauwels, Vincent Vandecaveye, Wies Deckers, Frederik Cleeren, Jeroen Dekervel, Timon Vandamme, Kim Serdons, Michel Koole, Guy Bormans, et al.
Pages: 1 - 13 - ¹⁸F-AlF-NOTA-octreotide outperforms ⁶⁸Ga-DOTA-TATE/-NOC PET in neuroendocrine tumor patients(2023)
Authors: Elin Pauwels, Frederik Cleeren, Térence Tshibangu, Michel Koole, Kim Serdons, Lennert Boeckxstaens, Jeroen Dekervel, Timon Vandamme, Willem Lybaert, Bliede Van den Broeck, et al.
Pages: 632 - 638 - Characterization of structurally diverse ¹⁸F-labeled d-TCO derivatives as a PET probe for bioorthogonal pretargeted imaging(2023)
Authors: Karuna Adhikari, Christel Vangestel, Pieter Van Der Veken, Sigrid Stroobants, Filipe Elvas, Koen Augustyns
Pages: 38252 - 38262 - MRI Apparent Diffusion Coefficient (ADC) as a biomarker of tumour response(2023)
Authors: Alan Jackson, Ryan Pathak, Nandita M. deSouza, Yan Liu, Bart K.M. Jacobs, Saskia Litiere, Maria Urbanowicz-Nijaki, Catherine Julie, Arturo Chiti, Jens Theysohn, et al.
Pages: 1 - 15 - The clinical value of combined FDG-PET/CT imaging in response evaluation after chemoradiotherapy in patients with potentially operable locally advanced head and neck squamous cell carcinoma(2023)
Authors: Nils Helsen, Sigrid Stroobants, Tim Van den Wyngaert, Laurens Carp
Number of pages: 148 - ¹⁸F-FDG and ¹⁸F-FLT uptake profiles for breast cancer cell lines treated with targeted PI3K/Akt/mTOR therapies(2023)
Authors: Yanina Dockx, Christel Vangestel, Sven De Bruycker, Tim Van den Wyngaert, Manon Huizing, Steven Staelens, Sigrid Stroobants
Pages: 51 - 61 - Synaptic vesicle glycoprotein 2A is affected in the CNS of Huntington’s Disease mice and post-mortem human HD brain(2022)
Authors: Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda Menchaca, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, et al.
Pages: 942 - 947 - Quantification of metabotropic glutamate receptor 5 availability with both [¹¹C]ABP688 and [¹⁸F]FPEB positron emission tomography in the Sapap3 knockout mouse model for obsessive-compulsive–like behavior(2022)
Authors: Dorien Glorie, Jeroen Verhaeghe, Alan Miranda Menchaca, Sigrid Stroobants, Steven Staelens
Pages: 607 - 615
Patents
1 - 3 of 3